Catalio Capital Management as of March 31, 2026
Portfolio Holdings for Catalio Capital Management
Catalio Capital Management holds 41 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | 9.8 | $47M | 560k | 83.92 | |
| Bridgebio Pharma (BBIO) | 6.7 | $32M | 432k | 74.26 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 6.2 | $30M | 129k | 228.73 | |
| Bristol Myers Squibb (BMY) | 5.3 | $26M | 421k | 60.65 | |
| Syndax Pharmaceuticals (SNDX) | 5.1 | $24M | 1.0M | 23.36 | |
| Gilead Sciences (GILD) | 4.8 | $23M | 164k | 139.37 | |
| Terns Pharmaceuticals (TERN) | 4.5 | $22M | 409k | 52.72 | |
| Definium Therapeutics Com Shs (DFTX) | 4.1 | $20M | 1.0M | 18.90 | |
| Soleno Therapeutics (SLNO) | 4.0 | $19M | 578k | 33.48 | |
| Boston Scientific Corporation (BSX) | 3.9 | $19M | 299k | 62.75 | |
| Ultragenyx Pharmaceutical (RARE) | 3.7 | $18M | 851k | 20.95 | |
| Incyte Corporation (INCY) | 3.6 | $17M | 182k | 94.12 | |
| Cytokinetics Com New (CYTK) | 3.0 | $14M | 216k | 65.91 | |
| Natera (NTRA) | 3.0 | $14M | 71k | 199.99 | |
| Corvus Pharmaceuticals (CRVS) | 2.7 | $13M | 892k | 14.63 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.6 | $12M | 255k | 48.20 | |
| Mineralys Therapeutics (MLYS) | 2.5 | $12M | 439k | 27.09 | |
| Edwards Lifesciences (EW) | 2.4 | $12M | 145k | 80.08 | |
| Veradermics Common Stock | 2.3 | $11M | 174k | 63.15 | |
| Adaptive Biotechnologies Cor (ADPT) | 2.1 | $10M | 723k | 13.88 | |
| Heartflow Inc/Sh (HTFL) | 2.1 | $9.8M | 404k | 24.33 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $8.6M | 427k | 20.13 | |
| Uniqure Nv SHS (QURE) | 1.7 | $8.0M | 491k | 16.35 | |
| Disc Medicine (IRON) | 1.6 | $7.9M | 123k | 63.94 | |
| Septerna (SEPN) | 1.5 | $7.1M | 294k | 24.03 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.1 | $5.3M | 47k | 111.35 | |
| Dyne Therapeutics (DYN) | 1.1 | $5.1M | 283k | 18.13 | |
| Eledon Pharmaceuticals (ELDN) | 1.1 | $5.1M | 1.6M | 3.08 | |
| Karyopharm Therapeutics Com New (KPTI) | 1.0 | $5.0M | 898k | 5.57 | |
| Supernus Pharmaceuticals (SUPN) | 0.7 | $3.2M | 62k | 51.69 | |
| Protara Therapeutics Com Stk (TARA) | 0.6 | $3.0M | 580k | 5.21 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $2.8M | 248k | 11.11 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.6 | $2.7M | 84k | 32.01 | |
| Tyra Biosciences (TYRA) | 0.5 | $2.6M | 67k | 38.30 | |
| Immunocore Hldgs Ads (IMCR) | 0.5 | $2.5M | 84k | 30.15 | |
| Fractyl Health (GUTS) | 0.5 | $2.5M | 5.5M | 0.46 | |
| Hyperfine Com Cl A (HYPR) | 0.3 | $1.4M | 1.3M | 1.08 | |
| Metagenomi (MGX) | 0.1 | $709k | 529k | 1.34 | |
| Ataibeckley Com Shs (ATAI) | 0.1 | $697k | 197k | 3.54 | |
| Sensei Biotherapeutics Com New (SNSE) | 0.1 | $464k | 15k | 31.52 | |
| Outset Med Com New (OM) | 0.1 | $454k | 118k | 3.84 |
